Mission
The ILD Collaborative, under the Pulmonary Care and Research Collaborative (PCRC), works towards creating collaborative networks among patients, clinicians, and researchers to enable larger, more efficient clinical studies for improving patient outcomes in interstitial lung diseases (ILD). Their infrastructure leverages advanced biocompatible technology and real-time population health research.
Basic Information
Tax-Exempt
Founded in
2013
EIN
46-1916701
Total Assets
$198 thousand
At a Glance
Project ECHO for ILD
A comprehensive educational program designed to improve care and outcomes for patients with ILD.
Virtual Community Meetings
Weekly virtual meetings that provide support and information for patients and caregivers.
Patient Symposium
An event aimed at engaging patients and enhancing understanding of ILD.
Upcoming Events
Monthly Palliative Care Series
2024-11-21
A series focused on improving palliative care approaches for patients.
Learn MoreMonthly Emotional/Mental Health Series
2024-11-26
Support meetings focused on the emotional and mental health aspects of living with ILD.
Learn MoreMonthly Lung Transplant Series
2024-12-02
Educational sessions about lung transplants and care for ILD patients.
Learn MoreMIP Score (Beta)
The MIP Score is in beta! We'd love any feedback you may have.
The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.
Overall Score
44
38
/100
Program Expense Ratio
90.65%
20
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0.465
8
/20
Working Capital Ratio
0.5124
6
/20
Fundraising Efficiency
0
2
/20
Latest Filing Data: Form 990
Fiscal Year:2022
Source:Source: Self-reported by organization
Financial Details
Revenue
| Category | Amount | Percentage |
|---|---|---|
| Contributions, Gifts, and Grants | 392.9K | 100.00% |
| Program Services | 0 | 0.00% |
| Investment Income | 0 | 0.00% |
| Sales of Non-Inventory Assets | 0 | 0.00% |
| Other Notable Sources | 0 | 0.00% |
| Total Revenue | 392.9K | 100.00% |
Related Nonprofits
Peter and Tommy Fund Inc. C/O Gary L Mucci
Med Research
Lung Disease ResearchLifelung
Med Research
Lung Disease ResearchSole of A Phoenix
Med Research
Lung Disease ResearchInternational Liver Transplantation Society
Med Research
Lung Disease ResearchAddario Lung Cancer Medical Institute
Med Research
Lung Disease Research